DE69033453D1 - Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose - Google Patents

Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose

Info

Publication number
DE69033453D1
DE69033453D1 DE69033453T DE69033453T DE69033453D1 DE 69033453 D1 DE69033453 D1 DE 69033453D1 DE 69033453 T DE69033453 T DE 69033453T DE 69033453 T DE69033453 T DE 69033453T DE 69033453 D1 DE69033453 D1 DE 69033453D1
Authority
DE
Germany
Prior art keywords
peptides
recombinant polypeptides
nucleic acids
acids coding
coding therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033453T
Other languages
English (en)
Other versions
DE69033453T2 (de
Inventor
Jean Content
Wit Lucas De
Bruyn Jacqueline De
Vooren Jean Paul Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Publication of DE69033453D1 publication Critical patent/DE69033453D1/de
Application granted granted Critical
Publication of DE69033453T2 publication Critical patent/DE69033453T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Endoscopes (AREA)
DE69033453T 1989-09-19 1990-09-19 Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose Expired - Fee Related DE69033453T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402571 1989-09-19

Publications (2)

Publication Number Publication Date
DE69033453D1 true DE69033453D1 (de) 2000-03-16
DE69033453T2 DE69033453T2 (de) 2000-09-21

Family

ID=8202993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69033453T Expired - Fee Related DE69033453T2 (de) 1989-09-19 1990-09-19 Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose

Country Status (10)

Country Link
US (3) US5916558A (de)
JP (2) JP2756368B2 (de)
AT (1) ATE189684T1 (de)
AU (1) AU631460B2 (de)
CA (1) CA2042016C (de)
DD (1) DD295869A5 (de)
DE (1) DE69033453T2 (de)
ES (1) ES2144394T3 (de)
IL (1) IL95742A (de)
WO (1) WO1991004272A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD295869A5 (de) * 1989-09-19 1991-11-14 �K�K@������������@�K�Kk�� Rekombinante polypeptide und peptide, diese codierende nucleinsaeuren und verwendung dieser polypeptide und peptide in der diagnose von tuberkulose
US7083797B2 (en) * 1990-09-19 2006-08-01 N.V. Innogenetics S.A. 32-kDa protein derived from Mycobacterium tuberculosis and related peptides
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
AU1097795A (en) * 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
AU2001271963A1 (en) * 2000-07-10 2002-01-21 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays
ZA200400843B (en) * 2001-08-02 2007-11-28 Univ New York Early detection of mycobacterial disease using peptides
MX2007005256A (es) 2004-11-16 2008-03-11 Crucell Holland Bv Vacunas multivalentes que comprenden vectores virales recombinantes.
US20070081944A1 (en) * 2005-09-30 2007-04-12 Reed Steven G Iontophoresis apparatus and method for the diagnosis of tuberculosis
US8628597B2 (en) * 2009-06-25 2014-01-14 3M Innovative Properties Company Method of sorting abrasive particles, abrasive particle distributions, and abrasive articles including the same
US8784774B2 (en) 2011-09-16 2014-07-22 General Electric Company Labeled molecular imaging agents and methods of use
US9468692B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use
US9468693B2 (en) 2014-01-23 2016-10-18 General Electric Company Labeled molecular imaging agents and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
BE905582A (fr) * 1986-10-09 1987-04-09 Province De Brabant Inst Paste Procede de production et de purification d'antigenes proteiques de mycobacterium bovis-bcg, produits obtenues et leurs applications.
GB8709803D0 (en) * 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
DD295869A5 (de) * 1989-09-19 1991-11-14 �K�K@������������@�K�Kk�� Rekombinante polypeptide und peptide, diese codierende nucleinsaeuren und verwendung dieser polypeptide und peptide in der diagnose von tuberkulose
US7083797B2 (en) * 1990-09-19 2006-08-01 N.V. Innogenetics S.A. 32-kDa protein derived from Mycobacterium tuberculosis and related peptides

Also Published As

Publication number Publication date
IL95742A0 (en) 1991-06-30
JP2756368B2 (ja) 1998-05-25
JPH09234096A (ja) 1997-09-09
JPH04501811A (ja) 1992-04-02
ATE189684T1 (de) 2000-02-15
CA2042016A1 (en) 1991-03-20
AU6414390A (en) 1991-04-18
DE69033453T2 (de) 2000-09-21
DD295869A5 (de) 1991-11-14
US6531138B1 (en) 2003-03-11
JP2872172B2 (ja) 1999-03-17
WO1991004272A1 (en) 1991-04-04
US7279170B2 (en) 2007-10-09
US20070003569A1 (en) 2007-01-04
AU631460B2 (en) 1992-11-26
CA2042016C (en) 2004-04-06
ES2144394T3 (es) 2000-06-16
US5916558A (en) 1999-06-29
IL95742A (en) 2000-12-06

Similar Documents

Publication Publication Date Title
DE69033453D1 (de) Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose
NO864369D0 (no) Polypeptider som er komplementaere til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent.
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
DE59504181D1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
IL100938A0 (en) Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis
ATE319091T1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ATE368053T1 (de) Antimikrobielle peptide
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
DK156592D0 (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DE3786649D1 (de) Pferde-gamma-interferon.
Otin et al. The complete amino acid sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC) from one individual
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
KR900016465A (ko) 사람의 macif 활성을 지닌 단백질을 암호화하는 유전자, 이 유전자를 함유하는 발현벡터, 형질전환 세포 및 사람 macif활성을 갖는 단백질
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
ATE120800T1 (de) Antigen-protein der sporozoit- und hepatischen phase von p. falciparum.
DK0426314T3 (da) HIV-relaterede peptider
ATE106944T1 (de) Rekombinante polypeptide des hämorrhagischen fisch-sepsis-virus.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
AR004485A1 (es) Insulina de cadena sencilla con alta bioactividad
ECSP961741A (es) Insulina de caneda sencilla con alta bioactividad (
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee